Get the latest news and updates on FINTECH.TV Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Advertisement Latest articles XBTO Highlights Growing Institutional Demand Beyond Bitcoin ETFs Market Movers: The Opening Bell December 12, 2025 ‘Einstein of Wall Street’ Breaks Down Markets After Fed Rate Cut Taking Stock December 12, 2025 ADX and NYSE Make History With First Dual-Listed ETFs From KraneShares Market Movers: The Opening Bell December 12, 2025 Worldpay Expands Crypto Payments Push as Merchants Eye Stablecoins Market Movers: The Opening Bell December 12, 2025 Related articles XBTO Highlights Growing Institutional Demand Beyond Bitcoin ETFs Market Movers: The Opening Bell December 12, 2025 ‘Einstein of Wall Street’ Breaks Down Markets After Fed Rate Cut Taking Stock December 12, 2025 ADX and NYSE Make History With First Dual-Listed ETFs From KraneShares Market Movers: The Opening Bell December 12, 2025